FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

391759008: Aminophylline hydrate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2006. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2621539016 Aminophylline hydrous en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2695031012 Aminophylline hydrate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2735934015 Aminophylline hydrate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4742201000005116 aminophyllinhydrat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Aminophylline hydrate Is a Aminophylline (substance) false Inferred relationship Some
Aminophylline hydrate Is a Aminophylline (substance) false Inferred relationship Some
Aminophylline hydrate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Aminophylline (substance) true Inferred relationship Some
Aminophylline hydrate Is a Vasodilator (substance) true Inferred relationship Some
Aminophylline hydrate Is a Methyl xanthine true Inferred relationship Some
Aminophylline hydrate Is a Ethylenediamine false Inferred relationship Some
Aminophylline hydrate Is a Bronchodilator (substance) true Inferred relationship Some
Aminophylline hydrate Is a Ethylenediamine and/or ethylenediamine derivative true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
aminophyllin 100 mg tablet med modificeret udløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aminophylline hydrate Inferred relationship Some
aminophyllin 225 mg tablet med modificeret udløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aminophylline hydrate Inferred relationship Some
aminophyllin 350 mg tablet med modificeret udløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aminophylline hydrate Inferred relationship Some
Product containing precisely aminophylline hydrate 25 milligram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Aminophylline hydrate Inferred relationship Some 1
Product containing precisely aminophylline hydrate 25 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Aminophylline hydrate Inferred relationship Some 1
Aminophylline hydrate 225 mg prolonged-release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Aminophylline hydrate Inferred relationship Some 1
Aminophylline hydrate 225 mg prolonged-release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Aminophylline hydrate Inferred relationship Some 1
Product containing precisely aminophylline hydrate 350 milligram/1 each prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Aminophylline hydrate Inferred relationship Some 1
Product containing precisely aminophylline hydrate 350 milligram/1 each prolonged-release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Aminophylline hydrate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start